Evidence before novelty.
A new test or intervention is not automatically useful because it has molecular vocabulary and a premium price.
Precision health works only when good science, individual context, professional judgement and data protection are handled together.

A new test or intervention is not automatically useful because it has molecular vocabulary and a premium price.
Preparation, temporary illness, medication, lifestyle and medical history can change what a result means.
Genetic and ageing signals describe probabilities or patterns, not a complete forecast of one person’s future.
Findings that require diagnosis or treatment belong in appropriate medical care, not inside a wellness slogan.
Biological-age methods may use DNA methylation, glycan patterns, routine clinical biomarkers or other molecular and physiological features. They can differ in purpose, sensitivity, repeatability and response to short-term change.
Nytheria explains the method used, its purpose, expected variability and limitations in clear language.
The molecular or clinical features behind the score.
Baseline description, risk research, change tracking or another defined purpose.
Analytical and biological variability must be considered before celebrating decimals.
No clock can replace a medical history, examination or multi-system view.
Genetic information can help identify inherited predispositions, inform conversations about screening or explain why some responses differ. Most complex health outcomes reflect interactions among many variants, environment, behaviour, age and chance.
Genetic insights are interpreted within a defined scope, with clear consent, appropriate review and careful handling of findings that may have wider implications.
See the genetics rolePeople should understand what is tested, what is not tested, who can access the result, how long data are kept and whether the information may have implications for relatives.
Every recommendation should pass through an explicit filter rather than emerging from a colourful dashboard with mysterious authority.
What supports the action, for which population and with what uncertainty?
Does the member’s context make the recommendation appropriate?
Could medication, disease, pregnancy, deficiency, excess or another factor change the risk?
What outcome will show whether the action helped, harmed or did nothing?
This public website collects contact information only. Clinical intake and genetic data will use a separate secure process with clear consent, access and retention rules.
Collect only what is necessary for a defined purpose.
Clear consent and privacy information in accessible language.
Role-based access, logging and clear professional responsibilities.
State how long data are kept and why.
Laboratories and technology providers must be contractually and technically reviewed.
Provide practical routes for access, correction, objection and deletion where applicable.
Nytheria presents the evidence behind its assessments and recommendations in a clear, accessible format.
López-Otín and colleagues’ updated framework organises major mechanisms of ageing while also showing why no single marker captures the entire process.
The geroscience framework examines shared biological processes linking ageing with multiple chronic conditions.
KoleQuant’s research direction reviews how long-lived and regenerative species can inform hypotheses while separating biological interest from clinical readiness.
Nytheria is not a replacement for licensed medical diagnosis, emergency care or specialist treatment.
No biomarker programme can guarantee disease prevention, reverse ageing or add a specified number of years to life.
Most complex outcomes cannot be predicted with certainty from selected genetic variants.
Reference ranges, decision thresholds and individual targets serve different purposes and require professional context.
Join early access for Nytheria programme and launch updates.
Apply for early access